Lipid Nanoparticle (LNP) Mediated mRNA Delivery in Cardiovascular Diseases: Advances in Genome Editing and CAR T Cell Therapy

Investigators conclude that the strategies to facilitate the extra-hepatic delivery and targeted organ tropism of mRNA-lipid nanoparticles (LNPs) hold great prospects to accelerate the development and translation of mRNA-LNPs in cardiovascular disease treatment.